Webinar: Best Practices vs. Band-Aids for Healing Leaky Gut and Stopping Chronic Inflammation
On-demand Webinar| Free
The aim of this webinar is to discuss the need for real solutions when it comes to healing leaky gut and curtailing the chronic inflammation that is associated with intestinal permeability. Bovine colostrum heals the G.I. lining, keeps the tight junctions tight, and prevents the "brown river" from mixing with the "red river". Halting the flow of toxins into the body reduces inflammation and puts patients on the path to true healing. With bovine colostrum, it is possible to improve the health outcome for patients with allergies, autoimmune conditions, mental illnesses, and other chronic debilitating conditions that otherwise cause disability and pain.
Douglas Wyatt, J.D., Director of the Sovereign Health Initative
Douglas Wyatt, J.D. is the founder and CEO of Sovereign Laboratories LLC, a Sedona-based company dedicated to developing natural products that provide the public with the best solutions for optimal health. He is honored to be listed as the leading expert in colostrum and is credited with reintroducing bovine colostrum into human use. Additionally, he serves as the director of the Sovereign Health Initiative, a 501(c)(3) nonprofit organization dedicated to recognition of personal health sovereignty and the belief that one’s commitment is essential to achieving optimal health and well-being. Mr. Wyatt is a leader in the research and a proponent of colostrum’s unique and powerful healing components that show incredible promise for turning the tide on the prevention and treatment of the world’s increasing chronic disease epidemic. As a publisher, author, writer, scientist, and public speaker, Mr. Wyatt has appeared nationwide on television and radio shows and at health conventions worldwide. He is dedicated to the prevention of chronic disease through natural nutritional intervention and has worked with the World Health Organization and other internationally recognized research organizations on clinical trials on HIV/AIDS other infectious disease, autoimmune disease, and bowel health issues.